These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis]. Germin Petrović D Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391 [TBL] [Abstract][Full Text] [Related]
23. The use of biocompatible dialysis membranes in acute renal failure. Himmelfarb J; Hakim RM Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):72-80. PubMed ID: 9113243 [TBL] [Abstract][Full Text] [Related]
24. Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon. Martin-Malo A; Velasco F; Rojas R; Castillo D; Rodriguez M; Torres A; Aljama P Kidney Int Suppl; 1993 Jun; 41():S213-6. PubMed ID: 8320924 [TBL] [Abstract][Full Text] [Related]
28. Biocompatibility of hemodialysis using cuprophane membranes. Rommes JH; Sangster B; Borst C; Daha MR; van Heijst NP Vet Hum Toxicol; 1987 Aug; 29(4):293-9. PubMed ID: 3629907 [TBL] [Abstract][Full Text] [Related]
29. Biocompatible membranes and hemodynamic tolerance to hemodialysis. Branger B; Deschodt G; Oules R; Balducchi JP; Granolleras C; Alsabadani B; Fourcade J; Shaldon S Kidney Int Suppl; 1988 Mar; 24():S196-7. PubMed ID: 3163048 [No Abstract] [Full Text] [Related]
30. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. Kabasakal C; Mir S; Gousseinov A; Cura A; Betin N; Coker I Turk J Pediatr; 1998; 40(3):413-20. PubMed ID: 9763906 [TBL] [Abstract][Full Text] [Related]
31. [The influence of dialysis dose and the dialyzer membrane biocompatibility on the outcome of acute renal failure]. Kes P; Sefer S Lijec Vjesn; 1999; 121(9-10):326-8. PubMed ID: 19662688 [No Abstract] [Full Text] [Related]
32. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility? Ward RA Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427 [No Abstract] [Full Text] [Related]
33. Are biocompatible membranes superior for hemodialysis therapy? van Ypersele de Strihou C Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694 [No Abstract] [Full Text] [Related]
34. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. Floege J; Koch KM Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985 [No Abstract] [Full Text] [Related]
35. [Membrane biocompatibility in dialysis: the role of absorption]. Chanard J Nephrologie; 2003; 24(7):359-65. PubMed ID: 14650747 [TBL] [Abstract][Full Text] [Related]
36. Nature of membrane, permeability, and biocompatibility in hemodialysis. Guiserix J Nephron; 1998; 78(3):349. PubMed ID: 9546704 [No Abstract] [Full Text] [Related]
37. The role of platelet-activating factor in the biocompatibility of hemodialysis membranes. Tetta C; Haeffner-Cavaillon N; Navino C; David S; Franceschi C; Mariano F; Camussi G Adv Exp Med Biol; 1996; 416():243-8. PubMed ID: 9131156 [No Abstract] [Full Text] [Related]
38. Efficiency and biocompatibility of membranes. Churchill DN Contrib Nephrol; 1995; 113():60-71. PubMed ID: 7712723 [No Abstract] [Full Text] [Related]